Generics Bulletin Explains: One Year On, US Humira Biosimilars Continue To Struggle For Share

After 12 Months Of US Competition, Uptake Remains Low For Adalimumab Biosimilars

 
• By David Wallace
  
Tiny slice of chocolate cake, pie chart, small market share concept
Biosimilars have captured a small market share, at lower prices • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products